NO180305C - Rekombinant DNA som koder for et mutein av basisk fibroblastvekstfaktor, transformant som kan produsere dette og fremgangsmåte for fremstilling derav - Google Patents
Rekombinant DNA som koder for et mutein av basisk fibroblastvekstfaktor, transformant som kan produsere dette og fremgangsmåte for fremstilling deravInfo
- Publication number
- NO180305C NO180305C NO880719A NO880719A NO180305C NO 180305 C NO180305 C NO 180305C NO 880719 A NO880719 A NO 880719A NO 880719 A NO880719 A NO 880719A NO 180305 C NO180305 C NO 180305C
- Authority
- NO
- Norway
- Prior art keywords
- fibroblast growth
- basic fibroblast
- producing
- preparation
- growth factor
- Prior art date
Links
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 title 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 title 1
- 108020004511 Recombinant DNA Proteins 0.000 title 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 abstract 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 abstract 1
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 210000001043 capillary endothelial cell Anatomy 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 229940126585 therapeutic drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4221887 | 1987-02-24 | ||
JP4344487 | 1987-02-25 | ||
JP8197787 | 1987-04-02 | ||
JP14751187 | 1987-06-12 | ||
JP20151087 | 1987-08-11 | ||
JP29028387 | 1987-11-17 | ||
JP63016260A JP2526965B2 (ja) | 1987-02-24 | 1988-01-26 | ムテイン,dnaおよびその用途 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO880719D0 NO880719D0 (no) | 1988-02-18 |
NO880719L NO880719L (no) | 1988-08-25 |
NO180305B NO180305B (no) | 1996-12-16 |
NO180305C true NO180305C (no) | 1997-03-26 |
Family
ID=27563743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO880719A NO180305C (no) | 1987-02-24 | 1988-02-18 | Rekombinant DNA som koder for et mutein av basisk fibroblastvekstfaktor, transformant som kan produsere dette og fremgangsmåte for fremstilling derav |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0281822B1 (fi) |
JP (1) | JP2526965B2 (fi) |
KR (1) | KR960013574B1 (fi) |
CN (1) | CN1031893C (fi) |
AT (1) | ATE108829T1 (fi) |
AU (1) | AU613564B2 (fi) |
CS (1) | CS407691A3 (fi) |
DE (1) | DE3850690T2 (fi) |
DK (1) | DK173269B1 (fi) |
ES (1) | ES2056842T3 (fi) |
FI (1) | FI96316C (fi) |
IE (1) | IE64299B1 (fi) |
IL (1) | IL85473A (fi) |
NO (1) | NO180305C (fi) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852177A (en) * | 1987-02-24 | 1998-12-22 | Takeda Chemical Industries, Ltd. | Basic fibroblast growth factor (bFGF) muteins |
WO1988010269A1 (en) * | 1987-06-18 | 1988-12-29 | Monash University | Growth factors |
AU611614B2 (en) * | 1987-06-18 | 1991-06-13 | Monash University | Growth factors |
GB8821795D0 (en) * | 1988-09-16 | 1988-10-19 | Erba Carlo Spa | New derivatives of human/bovine basic fibroplast growth factor |
US5352589A (en) * | 1988-09-16 | 1994-10-04 | Farmitalia Carlo Erba S.R.L. | Deletion mutant of basic fibroblast growth factor and production thereof |
US5120715A (en) * | 1988-12-12 | 1992-06-09 | Takeda Chemical Industries, Ltd. | Method for purifying fibroblast growth factor protein |
US5464943A (en) * | 1989-04-26 | 1995-11-07 | Takeda Chemical Industries, Ltd. | DNA encoding glycosylated FGF and production thereof |
CA2015313A1 (en) * | 1989-04-26 | 1990-10-26 | Masaharu Senoo | Glycosylated fgf and production thereof |
CA2020654A1 (en) * | 1989-07-07 | 1991-01-08 | Yohko Akiyama | Stabilized fgf composition and production thereof |
WO1991009954A1 (en) * | 1989-12-27 | 1991-07-11 | Resnick Michael A | Novel system for isolating and producing new genes, gene products and dna sequences |
CA2069872A1 (en) | 1989-12-28 | 1991-06-29 | Yoshio Kozai | Monoclonal antibody, hybridomas, their production and use |
JPH047617A (ja) * | 1990-04-26 | 1992-01-13 | Canon Inc | 電子機器 |
US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
US5206354A (en) * | 1990-11-23 | 1993-04-27 | American Cyanamid Company | Dna sequence encoding active fragment of fibroblast growth factor, hbf-2 |
CA2056142A1 (en) | 1990-11-27 | 1992-05-28 | Hirotomo Masuya | Pyridopyridazine compounds and their use |
DE69211723T2 (de) * | 1991-02-15 | 1996-10-31 | Takeda Chemical Industries Ltd | Mit einem Zellwachstumsfaktor bewirkte Anregung von Wachstum im Knocheninneren |
ATE138102T1 (de) * | 1991-02-19 | 1996-06-15 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von cysteinfreien peptiden |
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
TW209174B (fi) | 1991-04-19 | 1993-07-11 | Takeda Pharm Industry Co Ltd | |
JP3303211B2 (ja) * | 1991-04-26 | 2002-07-15 | 武田薬品工業株式会社 | bFGFムテインおよびその製造法 |
US5461029A (en) * | 1992-04-24 | 1995-10-24 | American Cyanamid Company | Method of treating herpes viral infections using HBNF and MK proteins |
US6805865B1 (en) * | 1993-05-27 | 2004-10-19 | Entremed, Inc. | Compositions and methods for treating cancer and hyperproliferative disorders |
JPH07114789B2 (ja) * | 1993-08-26 | 1995-12-13 | 工業技術院長 | 上肢動作補助機構 |
ATE299181T1 (de) * | 1993-09-24 | 2005-07-15 | Wyeth Corp | Strukturelle analoge oberflächenschlaufen der fibroblasten-wachstumsfaktoren |
JP2562413B2 (ja) * | 1993-11-04 | 1996-12-11 | 株式会社東京機械製作所 | 版胴における刷版装着装置 |
IT1269321B (it) * | 1994-04-15 | 1997-03-26 | Eniricerche Spa | Mutanti stabili della d-n- -carbamilasi |
US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
SI1541674T1 (sl) | 2002-06-18 | 2011-04-29 | Eisai R&D Man Co Ltd | Primarno kultivirani adipociti za gensko terapijo |
AU2007227256B2 (en) | 2006-03-20 | 2012-10-04 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
CN102690782A (zh) * | 2012-06-14 | 2012-09-26 | 安徽农业大学 | 一种成纤维细胞培养液 |
KR101610861B1 (ko) * | 2014-07-28 | 2016-04-11 | (주)케어젠 | 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도 |
CN105924532A (zh) * | 2016-06-08 | 2016-09-07 | 盘古基因生物工程(南京)股份有限公司 | 一种可溶性碱性成纤维细胞生长因子融合蛋白表达载体及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56026B1 (en) * | 1982-10-19 | 1991-03-27 | Cetus Corp | Cysteine-depleted muteins of biologically active proteins |
US4956455A (en) * | 1984-03-05 | 1990-09-11 | The Salk Institute For Biological Studies | Bovine fibroblast growth factor |
EP0593065B1 (en) * | 1985-09-12 | 2002-08-21 | Scios Inc. | Recombinant fibroblast growth factors |
EP0298723A1 (en) * | 1987-07-07 | 1989-01-11 | California Biotechnology, Inc. | Recombinant fibroblast growth factors |
KR890701607A (ko) * | 1987-11-24 | 1989-12-21 | 원본미기재 | 섬유아세포 성장 인자의 유사체 |
-
1988
- 1988-01-26 JP JP63016260A patent/JP2526965B2/ja not_active Expired - Lifetime
- 1988-02-18 NO NO880719A patent/NO180305C/no not_active IP Right Cessation
- 1988-02-19 IL IL85473A patent/IL85473A/xx not_active IP Right Cessation
- 1988-02-20 AT AT88102491T patent/ATE108829T1/de not_active IP Right Cessation
- 1988-02-20 DE DE3850690T patent/DE3850690T2/de not_active Expired - Lifetime
- 1988-02-20 ES ES88102491T patent/ES2056842T3/es not_active Expired - Lifetime
- 1988-02-20 EP EP88102491A patent/EP0281822B1/en not_active Expired - Lifetime
- 1988-02-23 DK DK198800926A patent/DK173269B1/da not_active IP Right Cessation
- 1988-02-23 AU AU12085/88A patent/AU613564B2/en not_active Expired
- 1988-02-23 IE IE48288A patent/IE64299B1/en not_active IP Right Cessation
- 1988-02-23 FI FI880845A patent/FI96316C/fi active IP Right Grant
- 1988-02-24 CN CN88100913A patent/CN1031893C/zh not_active Expired - Lifetime
- 1988-02-24 KR KR88001949A patent/KR960013574B1/ko not_active IP Right Cessation
-
1991
- 1991-12-27 CS CS914076A patent/CS407691A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
CN1031893C (zh) | 1996-05-29 |
JPH02193A (ja) | 1990-01-05 |
FI880845A0 (fi) | 1988-02-23 |
ATE108829T1 (de) | 1994-08-15 |
AU613564B2 (en) | 1991-08-01 |
CN88100913A (zh) | 1988-09-07 |
NO180305B (no) | 1996-12-16 |
KR960013574B1 (en) | 1996-10-09 |
DK92688A (da) | 1988-08-25 |
CS407691A3 (en) | 1992-06-17 |
JP2526965B2 (ja) | 1996-08-21 |
AU1208588A (en) | 1988-08-25 |
FI96316B (fi) | 1996-02-29 |
FI96316C (fi) | 1996-06-10 |
DE3850690T2 (de) | 1995-01-05 |
NO880719D0 (no) | 1988-02-18 |
EP0281822A2 (en) | 1988-09-14 |
DE3850690D1 (de) | 1994-08-25 |
EP0281822B1 (en) | 1994-07-20 |
NO880719L (no) | 1988-08-25 |
IL85473A (en) | 1997-03-18 |
IE64299B1 (en) | 1995-07-26 |
KR880010130A (ko) | 1988-10-07 |
FI880845A (fi) | 1988-08-25 |
IE880482L (en) | 1988-08-24 |
ES2056842T3 (es) | 1994-10-16 |
DK92688D0 (da) | 1988-02-23 |
EP0281822A3 (en) | 1990-03-21 |
DK173269B1 (da) | 2000-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO180305C (no) | Rekombinant DNA som koder for et mutein av basisk fibroblastvekstfaktor, transformant som kan produsere dette og fremgangsmåte for fremstilling derav | |
NO862964D0 (no) | Saarhelingsmidler. | |
NO905264D0 (no) | Fremgangsmaate for fremstilling av biologisk aktivt protein | |
ES2093025T3 (es) | Produccion del factor de crecimiento de celulas endoteliales y adn de codificacion del mismo. | |
ATE96329T1 (de) | Topisch anwendbare pharmazeutische zubereitung. | |
ES2057544T3 (es) | Composiciones estabilizadas a base de fgf. | |
ATE189393T1 (de) | Therapeutisches agens zur wundbehandlung | |
CA2011008A1 (en) | Egf variants and pharmaceutical use thereof | |
DE69434997D1 (de) | Menschliches Chondromodulin-I-Protein | |
DE68909254D1 (de) | Heparinbindende Gehirnmitogene. | |
ATE120799T1 (de) | Mutein von hst-1 und seine herstellung. | |
ATE108331T1 (de) | Verwendung von tnf zur herstellung eines arzneimittels zur behandlung von psoriasis. | |
DE69130818D1 (de) | Chondromodulin-I-Protein | |
Hoover | Endothelial cell growth factors in atherogenesis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |